Table 4.
Features of Early Reactions to AV | No. of Cases (% of Total 180 Cases That Received AV) | No. of Courses (% of Total 285 Courses of AV) |
---|---|---|
Cutaneous | ||
Urticaria | 30 (16.7) | 31 (10.9) |
Pruritus | 6 (3.3) | 6 (2.1) |
Angioedema | 5 (2.8) | 5 (1.7) |
Gastrointestinal | ||
Nausea and vomiting | 2 (1.1) | 2 (0.7) |
Respiratory | ||
Chest tightness | 17 (9.4) | 17 (5.9) |
Wheezing | 4 (2.2) | 4 (1.4) |
Hypoxemia | 4 (2.2) | 5 (1.7) |
Dyspnea | 2 (1.1) | 2 (0.7) |
Cardiovascular | ||
Tachycardia | 7 (3.9) | 7 (2.4) |
Hypotension | 4 (2.2) | 4 (1.4) |
Syncope | 1 (0.6) | 1 (0.3) |
Others | ||
Fever with chill | 3 (1.7) | 3 (1.1) |
Drowsy | 1 (0.6) | 1 (0.3) |
Treatments | ||
Adrenaline | 14 (7.8) | 14 (4.9) |
Dexamethasone IV | 16 (8.9) | 16 (5.6) |
Chlorpheniramine IV | 31 (17.2) | 31 (10.9) |
Ranitidine IV | 6 (3.3) | 6 (2.1) |
Hydrocortisone IV | 4 (2.2) | 4 (1.4) |
Meperidine IV | 1 (0.6) | 1 (0.3) |
Abbreviations: AV, antivenom; IV, intravenous.